Cannbiorx Life Sciences Stock Current Valuation
| ATNFW Stock | USD 0.01 0 34.09% |
Valuation analysis of CannBioRx Life Sciences helps investors to measure CannBioRx Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -0.03 in 2024. Enterprise Value Multiple is likely to drop to -0.03 in 2024.
Overvalued
Today
Please note that CannBioRx Life's price fluctuation is out of control at this time. Calculation of the real value of CannBioRx Life Sciences is based on 3 months time horizon. Increasing CannBioRx Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CannBioRx stock is determined by what a typical buyer is willing to pay for full or partial control of CannBioRx Life Sciences. Since CannBioRx Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CannBioRx Stock. However, CannBioRx Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0118 | Real 0.009618 | Hype 0.01 | Naive 0.0124 |
The intrinsic value of CannBioRx Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CannBioRx Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CannBioRx Life Sciences helps investors to forecast how CannBioRx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CannBioRx Life more accurately as focusing exclusively on CannBioRx Life's fundamentals will not take into account other important factors: CannBioRx Life Sciences Company Current Valuation Analysis
CannBioRx Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CannBioRx Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for CannBioRx Life is extremely important. It helps to project a fair market value of CannBioRx Stock properly, considering its historical fundamentals such as Current Valuation. Since CannBioRx Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CannBioRx Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CannBioRx Life's interrelated accounts and indicators.
Click cells to compare fundamentals
CannBioRx Current Valuation Historical Pattern
Today, most investors in CannBioRx Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CannBioRx Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CannBioRx Life current valuation as a starting point in their analysis.
CannBioRx Life Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CannBioRx Life Sciences has a Current Valuation of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
CannBioRx Life Sciences is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 15.02 Million. CannBioRx Life adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care industry.CannBioRx Fundamentals
| Return On Equity | -3.99 | ||||
| Return On Asset | -0.63 | ||||
| Number Of Shares Shorted | 10.74 K | ||||
| EBITDA | (22.13 M) | ||||
| Net Income | (19.94 M) | ||||
| Total Debt | 1.05 M | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (10.92 M) | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 250.78 M | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (127.34 M) | ||||
| Working Capital | (1.42 M) | ||||
| Net Asset | 5.26 M |
About CannBioRx Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.